PTSD News

Young adults with childhood history of both parental incarceration and juvenile justice involvement were more likely to have depression, anxiety or PTSD compared to those without either exposure, according to a study published in JAMA Network Open.

Findings published in Psychiatry Research revealed significant overlap between self-reported PTSD and obsessive-compulsive disorder symptoms.

Two recent studies concluded that although interest is strong, more research is needed before clinicians make treatment decisions regarding cannabis use in PTSD.

Researchers reported that clinically meaningful improvement in PTSD symptoms compared with less than clinically meaningful or no improvement was linked to a 49% lower risk for incident type 2 diabetes.

Veterans with a history of traumatic brain injury, or TBI, were twice as likely to die by suicide compared with veterans without history of TBI, findings from a large-scale study revealed.

Massachusetts General Hospital has been named the number one hospital for psychiatric care in America for 2019 to 2020, according to the U.S. News & World Report.

Study results indicated that patients with PTSD were at greater risk for death in the year following co-prescription of opioids and benzodiazepines than patients newly prescribed opioids only, benzodiazepines only or neither medication class.

The FDA has issued a warning letter to Curaleaf Inc. for illegally selling unapproved products containing cannabidiol, or CBD, online, claiming to treat Alzheimer’s disease, cancer, opioid withdrawal, pain and other conditions, according to a press release.

The potential of artificial intelligence and machine learning approaches to identify mental illness continues to be exciting area of research.

Compared with the general U.S. population, veterans with PTSD appeared at higher risk for death by suicide, accidental injury and viral hepatitis, according to data published in American Journal of Preventive Medicine.